Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linkagene is a Spanish biotechnology company specializing in the development, manufacture, and distribution of molecular diagnostic solutions for transplant immunology and transfusion medicine. The company provides a comprehensive portfolio of products focused on high-resolution typing of Human Leukocyte Antigens (HLA) and Killer-cell Immunoglobulin-like Receptors (KIR). Utilizing advanced technologies such as real-time PCR and Next-Generation Sequencing (NGS), Linkagene's tools are designed to enhance the precision and efficiency of histocompatibility testing in clinical laboratories. Their offerings also extend to pharmacogenetics and the diagnosis of genetic predispositions for autoimmune conditions like Coeliac disease and Narcolepsy. Headquartered in Madrid, Linkagene serves as a key partner for clinical and research institutions in the Iberian Peninsula, offering both proprietary diagnostic kits and distributing leading international brands. The company is ISO 13485 certified, ensuring high standards in the design and production of in vitro diagnostic medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Linkagene.